United States · FDA National Drug Code directory
Relief-PE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50332-0153_129bfe8e-117e-4a42-98eb-e25990b3f2a5
- Product NDC
- 50332-0153
- Form
- TABLET, COATED
- Composition / generic term
- ACETAMINOPHEN, PHENYLEPHRINE, CHLORPHENIRAMINE
- Labeler
- HART Health
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20120416
- Source listing expiry
- 20271231
Source-listed ingredients
- ACETAMINOPHEN — 325 mg/1
- PHENYLEPHRINE HYDROCHLORIDE — 5 mg/1
- CHLORPHENIRAMINE MALEATE — 2 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, COATED in 1 BOX, UNIT-DOSE (50332-0153-4) · 50332-0153-4
- 250 TABLET, COATED in 1 BOX, UNIT-DOSE (50332-0153-7) · 50332-0153-7
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →